These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6330549)

  • 1. Idiopathic hyperaldosteronism. A possible role for aldosterone-stimulating factor.
    Carey RM; Sen S; Dolan LM; Malchoff CD; Bumpus FM
    N Engl J Med; 1984 Jul; 311(2):94-100. PubMed ID: 6330549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin-responsive aldosterone-producing adenoma masquerades as idiopathic hyperaldosteronism (IHA: adrenal hyperplasia) or low-renin essential hypertension.
    Gordon RD; Gomez-Sanchez CE; Hamlet SM; Tunny TJ; Klemm SA
    J Hypertens Suppl; 1987 Dec; 5(5):S103-6. PubMed ID: 2832571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of ACTH in the episodic release of aldosterone in patients with idiopathic adrenal hyperplasia, hypertension, and hyperaldosteronism.
    Kem DC; Weinberger MH; Gomez-Sanchez C; Higgins JR; Kramer NJ
    J Lab Clin Med; 1976 Aug; 88(2):261-70. PubMed ID: 182890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of aldosterone secretion in primary aldosteronism.
    Vetter H; Vetter W
    Horm Metab Res; 1975 Sep; 7(5):418-24. PubMed ID: 1183923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An unexpected rise in plasma aldosterone to furosemide-upright test in primary aldosteronism due to aldosterone producing adenoma.
    Shigemasa C; Kouchi T; Yoshida A; Mashiba H
    J Med; 1991; 22(3):187-93. PubMed ID: 1663149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The plasma aldosterone response to angiotensin II infusion in aldosterone-producing adenoma and idiopathic hyperaldosteronism.
    Wisgerhof M; Brown RD; Hogan MJ; Carpenter PC; Edis AJ
    J Clin Endocrinol Metab; 1981 Feb; 52(2):195-8. PubMed ID: 7462385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aldosterone and renin-angiotensin responses to stimuli in patients with treated congestive heart failure.
    Nicholls MG; Espiner EA; Donald RA
    J Lab Clin Med; 1976 Jun; 87(6):1005-15. PubMed ID: 180213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of aldosterone by cyproheptadine in idiopathic aldosteronism.
    Gross MD; Grekin RJ; Gniadek TC; Villareal JZ
    N Engl J Med; 1981 Jul; 305(4):181-5. PubMed ID: 7017408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced response to metoclopramide and anomalous rising response to upright posture of plasma aldosterone concentration in Japanese patients with aldosterone-producing adenoma.
    Mune T; Morita H; Yasuda K; Yamakita N; Miura K
    J Clin Endocrinol Metab; 1993 Oct; 77(4):1020-7. PubMed ID: 8408449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circadian rhythm of plasma aldosterone concentration in patients with primary aldosteronism.
    Kem DC; Weinberger MH; Gomez-Sanchez C; Kramer NJ; Lerman R; Furuyama S; Nugent CA
    J Clin Invest; 1973 Sep; 52(9):2272-7. PubMed ID: 4353776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Primary hyperaldosteronism--12 clinical cases].
    Telles EC; Machado FS; da Silva EP; Lutucuta S; Almeida G; Coucelo J; Vagueiro C
    Rev Port Cardiol; 1999 Sep; 18(9):801-12. PubMed ID: 10536470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circadian rhythm and effect of posture on plasma aldosterone concentration in primary aldosteronism.
    Schambelan M; Brust NL; Chang BC; Slater KL; Biglieri EG
    J Clin Endocrinol Metab; 1976 Jul; 43(1):115-31. PubMed ID: 947931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical, biochemical and genetic approaches to the detection of familial hyperaldosteronism type I.
    Stowasser M; Bachmann AW; Jonsson JR; Tunny TJ; Klemm SA; Gordon RD
    J Hypertens; 1995 Dec; 13(12 Pt 2):1610-3. PubMed ID: 8903619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of primary aldosteronism using the captopril test].
    Pirich K; Vierhapper H; Graninger W; Nowotny P; Waldhäusl W
    Wien Klin Wochenschr; 1987 Sep; 99(17):608-11. PubMed ID: 3314169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long term evolution of glucocorticoid-suppressible hyperaldosteronism.
    Stockigt JR; Scoggins BA
    J Clin Endocrinol Metab; 1987 Jan; 64(1):22-6. PubMed ID: 3536983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal adrenal responsiveness and angiotensin II dependency in high renin essential hypertension.
    Dluhy RG; Bavli SZ; Leung FK; Solomon HS; Moore TJ; Hollenberg NK; Williams GH
    J Clin Invest; 1979 Nov; 64(5):1270-6. PubMed ID: 500810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of bromocriptine treatment on the aldosterone response to angiotensin II and adrenocorticotropin in idiopathic hyperaldosteronism.
    Wisgerhof M; Mellinger RC
    J Clin Endocrinol Metab; 1985 Jul; 61(1):192-5. PubMed ID: 2987293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Rectal electrical potential difference and plasma aldosterone in hyperaldosteronism and low-, normal- and high-renin hypertension].
    Skrabal F; Mauser R
    Wien Klin Wochenschr; 1976 Dec; 88(23):777-81. PubMed ID: 1014711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased adrenal sensitivity to angiotensin II in idiopathic hyperaldosteronism.
    Wisgerhof M; Carpenter PC; Brown RD
    J Clin Endocrinol Metab; 1978 Nov; 47(5):938-43. PubMed ID: 400738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.